Open access · OA
via OpenAlex
A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults
American Journal of Clinical Nutrition · 2007 · ▲ 25 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/ajcn/86.4.1254a
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Kelly, C.J. (2007). A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. <em>American Journal of Clinical Nutrition</em>. https://doi.org/10.1093/ajcn/86.4.1254a
Vancouver
Kelly CJ. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. American Journal of Clinical Nutrition. 2007. doi:10.1093/ajcn/86.4.1254a.
BibTeX
@article{caleb2007Acontr,
title = {A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults},
author = {Caleb James Kelly},
journal = {American Journal of Clinical Nutrition},
year = {2007},
doi = {10.1093/ajcn/86.4.1254a},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Aspects of Medicine 2011
Citation only
Caloric restriction
Beijing Minhai Biotechnology Co., Ltd 2020
Open access · US-GOV
Evaluation of the Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above: a Randomized, Double-blind, Placebo Parallel-controlled Phase II Clinical Trial
Beijing Minhai Biotechnology Co., Ltd 2020
Open access · US-GOV
Evaluation of the Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above: a Randomized, Double-blind, Placebo Parallel-controlled Phase I Clinical Trial
Jiangsu Province Centers for Disease Control and Prevention 2021
Open access · US-GOV
A Single-center, Randomized, Double Blinded, Placebo Controlled, Phase 2 Clinical Trial of Recombinant COVID-19 Vaccine (CHO Cells), in the Subjects From Healthy Aged 18 Years and Above
Nature Communications 2014
Open access · OA
Methionine restriction extends lifespan of Drosophila melanogaster under conditions of low amino-acid status
Jiangsu Province Centers for Disease Control and Prevention 2021
Open access · US-GOV